Hoya Corp. (OTCMKTS:HOCPY - Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $129.89, but opened at $134.63. Hoya shares last traded at $134.63, with a volume of 439 shares traded.
Wall Street Analyst Weigh In
HOCPY has been the subject of a number of research analyst reports. Nomura Securities upgraded Hoya to a "strong-buy" rating in a report on Monday, August 18th. The Goldman Sachs Group upgraded shares of Hoya from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, July 23rd. Finally, Erste Group Bank raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a report on Friday, May 23rd. Three equities research analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, Hoya currently has a consensus rating of "Strong Buy".
Read Our Latest Report on HOCPY
Hoya Trading Up 3.6%
The business has a 50-day moving average price of $126.68 and a 200-day moving average price of $120.13. The company has a quick ratio of 4.46, a current ratio of 5.19 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $47.52 billion, a P/E ratio of 34.63, a PEG ratio of 2.92 and a beta of 0.94.
Hoya (OTCMKTS:HOCPY - Get Free Report) last posted its quarterly earnings results on Friday, August 1st. The technology company reported $1.05 earnings per share for the quarter, topping analysts' consensus estimates of $1.04 by $0.01. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.47 billion. Hoya had a net margin of 23.57% and a return on equity of 21.01%. Analysts anticipate that Hoya Corp. will post 3.66 earnings per share for the current year.
About Hoya
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Featured Articles
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.